Lymphocytosis promoting factor (LPF) 
Bordetella pertussis, the cause of human pertussis or whooping cough, produces a toxin called lymphocytosispromoting factor (LPF; synonyms: pertussis toxin, pertussigen, islet-activating protein, histamine-sensitizing factor). It has been proposed that LPF is responsible for the systemic manifestations of B. pertussis infection (37, 49) , and parallels have been observed between the effects of purified LPF in experimental animals and those signs observed in infected humans or animals. For example, administration of LPF sensitizes mice to the lethal effects of histamine (30, 31, 52) , induces leukocytosis and lymphocytosis (30, 31) , enhances the release of insulin (52) , inhibits epinephrine-induced hyperglycemia (30, 52) , and is an immunological adjuvant (2, 31) . Mice with respiratory infections show leukocytosis, histamine sensitization, and enhanced insulin release (15, 38, 40) . Humans with pertussis have a marked lymphocytosis and leukocytosis (37, 49) , and attenuation of epinephrineinduced hyperglycemia has been observed (3) .
No evidence has been developed, however, to implicate LPF in localized respiratory disease. Since B. pertussis causes a noninvasive infection which is restricted to the ciliated respiratory epithelium (28) , the effects of LPF on those host cells that might be involved at the site of infection were investigated. In initial studies, the functional and morphological effects of LPF on mononuclear phagocytes (MNPs) were examined. MNPs were chosen because they are (i) potent secretory and phagocytic effector cells both in the preimmune and immune stages of an infection (33) , (ii) important accessory cells in the induction of specific immune responses (47) , and (iii) important in the control of other respiratory infections (16, 19) . Furthermore, intact cells, cell extracts, or culture supernatant fluids of B. pertussis have been shown to alter phagocytic cell function (4, 9, 20, 27, 48) . MNPs (4, 27) and polymorphonuclear * Corresponding author.
leukocytes (20) in animals injected with pertussis vaccine or cell extracts had a decreased ability to migrate into a site of inflammation. Benjamin et al. (4) demonstrated that peritoneal macrophages from pertussis vaccine-treated mice exhibited decreased elongation and random migration in vitro. Others have reported an inhibition of chemotaxis, phagocytosis, oxidative metabolism, or bactericidal activity in MNPs (9) or polymorphonuclear leukocytes (9, 48) treated in vitro with an extract of B. pertussis. Different conclusions were reached on whether LPF was responsible for the observed effects. Since it is very likely that these cells or extracts contained LPF as well as other potentially toxic components such as lipopolysaccharide, extracytoplasmic adenylate cyclase, and dermonecrotic toxin, it is difficult to determine which component(s) was responsible for these effects on phagocytic cells. This paper examines the effects of highly purified LPF on MNP function and describes changes in morphology and function when mouse peritoneal macrophages are treated in vitro with LPF. The effects of LPF on MNP circulation and migration into a site of acute inflammation will be reported separately.
( (8) . LPF (either untreated or heat inactivated at 80°C for 30 min) at 1 ,ug/ml was negative in an assay able to detect 0.125 ng/ml of the U.S. Reference Endotoxin . LPF was assayed for adenylate cyclase activity by published procedures (51) , and at saturating levels of calmodulin (10-6 M) (51) , no activity could be detected in 1 Probe) with 5 ,um pores. At the start of the assay, 50 RI of either the peritoneal macrophages or the RAW264 cells was added to the cell chamber. Chambers were incubated at 37°C for 4 h in an atmosphere of 5% CO2 in humidified air, and migrated cells were quantitated as previously described (26) with an Optomax image analyzer (Optomax Inc., Hollis, N.H.).
Experiments to determine whether migrated macrophages fell off the underside of the filter before the end of the assay were performed in 13-mm blind-well chambers (Neuro Probe), some of which had a glass cover slip in the lower chamber. The cell preparation and assay conditions were as described above except that 0.4 ml of the cell suspension at 106 macrophages per ml in RPMI-BSA was added to the upper chamber and 200 ,u of the attractant was added to the lower chamber. At the conclusion of the experiment, a count was made of the number of macrophages attached to the attractant side of the filter, attached to the glass cover slips, and free in the lower chamber.
Quantitation of attached cells. In some experiments, the number of cells adhering to tissue-culture dishes (diameter, 16 mm; TC-24; Costar, Cambridge, Mass.) were counted by the method of Stewart (45) . Wells were washed to remove nonadherent cells, and a solution containing 3% cetrimide (hexadecyltrimethylammonium bromide; Sigma), 0.85% NaCl, and 0.037% disodium-EDTA was added to lyse the cytoplasmic membranes of attached cells. Liberated nuclei were counted in a Coulter Counter (model Z-BI; Coulter Electronics, Hialeah, Fla.).
Assay of Fc-mediated phagocytosis. Phagocytosis of radiolabeled, antibody-coated sheep erythrocytes (EA) by macrophages was assessed by the method of Snyderman et al. (43) , using macrophages cultured in TC-24 dishes. EA were prepared by incubating 1 ml of washed sheep erythrocytes (Truslow Farms, Chestertown, Md.) at 109/ml with both a nonagglutinating dilution of a rabbit antiserum (Cappel Laboratories, West Chester, Pa.) to sheep erythrocytes and 100 ,uCi of Na51CrO4 (200 to 500 Ci/g of chromium; New England Nuclear Corp., Boston, Mass.) at 37°C for 30 min. Washed EA were resuspended in RPMI-BSA or RPMI-2% FBS, and 2.5 x 107 EA were added to each macrophage culture.
Cultures were incubated for 60 min at 37°C and washed twice with phosphate-buffered saline, and noningested EA were lysed with 0.5 ml of an ammonium chloride-EDTA lysing buffer (ACK-lyse; NIH Media Unit, Bethesda, Md.). After two additional washes, 0.6 ml of 0.5% sodium dodecyl sulfate was added to each well. A 0.5-ml sample was removed from each well and counted in a Beckman gamma counter. Controls not containing macrophages were included in each assay. Phagocytosis was reported as the mean counts per minute of triplicate cultures.
Assay of superoxide production. Opsonized zymosan-stimulated superoxide anion release was assayed by the method described by Johnston (21) . Superoxide anion release was measured as superoxide dismutase (Sigma)-inhibitable ferricytochrome c (type III; Sigma) reduction (21) ent protocols. In protocol I, a suspension of peritoneal cells at 3 x 106 macrophages per ml in RPMI-BSA was mixed with an equal volume of RPMI-BSA containing 0, 4, or 40 ng of LPF per ml. Samples (0.65 ml) of this suspension were added to each well of a TC-24 plate and incubated at 37°C for 4 h. At this time, the cultures were assayed for phagocytosis or superoxide production. The phagocytosis assay was begun by adding 0.1 ml of EA at 2.5 x 108/ml to each well. For the superoxide assay, the culture fluids were carefully removed and replaced with 0.5 ml of Hanks balanced salt solution without phenol red (MA Bioproducts) containing 160 FM ferricytochrome c. In this protocol, nonadherent cells were not removed before the assays. In protocol II, 0.5 ml of a suspension of peritoneal cells at 106 macrophages per ml in RPMI-2% FBS was added to TC-24 plates. Plates were incubated at 37°C for 2 to 3 h, and nonadherent cells were removed by washing three times with Dulbecco phosphatebuffered saline. One ml of RPMI-2% FBS containing 0, 2, or 20 ng of LPF per ml was added to each culture and incubated for 16 to 20 h at 37°C. The culture fluids were then removed and replaced with either 0.5 ml of EA at 5 x 107 per ml in RPMI-2% FBS for the phagocytosis assay or 0.5 ml of Hanks balanced salt solution without phenol red containing 160 ,uM ferricytochrome c for the superoxide assay.
Antibodies specific for LPF. The gamma globulin fraction of serum from goats immunized with purified, glutaraldehyde-inactivated LPF was prepared (39) , and specific antibody was affinity purified by passage of the antiserum through a column of purified LPF covalently coupled to Sepharose-4B (Pharmacia Fine Chemicals, Piscataway, N.J.). Antibodies were eluted with 3 M KSCN, dialyzed extensively against phosphate-buffered saline, and stored at -200C.
Monoclonal antibodies to LPF were prepared by fusing, in the presence of polyethylene glycol, spleens of BALB/c mice hyperimmunized with glutaraldehyde-inactivated LPF with mouse plasmacytoma cell line SP2/O-Agl4 (M. Oda, J. L. Cowell, D. G. Burstyn, and C. R. Manclark, submitted for publication). Antibody-producing clones were injected into the peritoneal cavities of pristane-primed BALB/c mice, and ascitic fluids were collected, brought to 20% saturation with ammonium sulfate, and centrifuged to remove insoluble material. Gamma globulins in the supernatant fraction were precipitated in 50% saturated ammonium sulfate, dialyzed against phosphate-buffered saline, and stored at -20°C.
Microscopy of LPF-treated macrophages. The morphology of LPF-treated adherent cells was examined by light and scanning-electron microscopy. Peritoneal cells at 3 x 105 macrophages per ml were suspended in RPMI-BSA containing various concentrations of LPF. Peritoneal cells (0.5 ml) were added to wells in an eight-compartment Lab-Tek tissue culture slide (Miles Scientific, Div. of Miles Laboratories, Inc., Naperville, Ill.) and incubated for 4 h at 37°C. Slides with adherent macrophages were removed after incubation and washed three times in warm (37°C) Dulbecco phosphatebuffered saline to remove nonadherent cells. For light microscopy, slides were fixed for 15 min in PBS containing 2% glutaraldehyde and then stained with Diff-Quik. For scanning electron microscopy, slides were fixed in 2% glutaraldehyde-2% paraformaldehyde in cacodylate buffer, followed by two to three rinses in cacodylate buffer. The slides were scored and broken into sizes to fit the critical-point dryer. These pieces were dehydrated in graded ethanols and infiltrated with graded Freon TF (Textile Chemical Co., Baltimore, Md.) in preparation for critical-point drying. The samples were critical-point dried by the methods of De Harven et al. (10) , using Halocarbon 13 (Bel Welding Supply Co., Hyattsville, Md.), mounted on aluminum stubs with conductive paste, sputter coated with Au/Pd, and examined in an ETEC autoscan (ETEC-Perkin Elmer, Hayward, Calif.).
Statistical analysis. Results from experimental groups were compared by the Student t test. RESULTS Inhibition by LPF of the migration of C3H/HeN macrophages. In initial experiments, the effect of LPF on in vitro migration of resident peritoneal macrophages of C3H/HeN mice was examined. Migration was assessed by counting the macrophages migrating through thin Nuclepore filters at various concentrations of EAMS, a strong chemoattractant for mouse peritoneal macrophages (26) . Maximal migration in control cultures occurred at an EAMS concentration of 0.5% (vol/vol) (Fig. 1 ml inhibited migration by more than 80% at all attractant concentrations, including the random migration in the absence of EAMS (Fig. 1) . The dose response for LPF inhibition was determined in several experiments performed at the optimal attractant concentration. The combined results indicate that LPF at ca. 0.2 to 0.3 ng/ml reduced the migration to 50% of control (Fig. 2) . Migration in the absence of EAMS was not subtracted from these results since random migration was also inhibited by LPF.
In the experiments described above, cells were suspended in 2% BSA, but migration was also assayed in the presence of 2 to 5% FBS. Although the migration in FBS was quantitatively less than in BSA, the inhibition curve for LPF was similar to that shown in Fig. 2 (data not shown) .
Inhibition of migration of C3H/HeJ macrophages and the RAW264 macrophage-like cell line. Similar experiments were performed with resident peritoneal macrophages from endotoxin-hyporesponsive C3H/HeJ mice and cells of the cloned macrophage-like line RAW264. The migration of both cell types was inhibited by LPF (Fig. 3) . The inhibition curve for C3H/HeJ macrophages was very similar to that for C3H/ HeN macrophages. Fifty percent inhibition occurred at ca. 0.2 ng/ml. As observed with C3H/HeN mice, the random migration was also inhibited by LPF (data not shown). Approximately 1 to 2 ng of LPF per ml caused a 50% inhibition of the migration of the RAW264 cells, a concentration 5-to 10-fold higher than that for the resident peritoneal macrophages. In the absence of EAMS, migration of the cell line was too low to determine whether random migration also was reduced by LPF.
LPF does not reduce macrophage viability or adherence. Resident peritoneal cells with or without LPF were added to tissue culture dishes and incubated for 4 to 6 h. The viability after culture of adherent and nonadherent cells was greater than 95% in all preparations and was not reduced by LPF at concentrations up to 100 ng/ml. The number of adherent cells was also not changed in cultures containing 20 ng of LPF per ml, the highest concentration tested (see Tables 1  and 2 ). In the chemotaxis assays, LPF did not cause the migrated macrophages to fall off the underside of the polycarbonate filter before the end of the 4-h assay. In both control wells and wells with 5 ng of LPF per ml, less than 10% of the migrated macrophages could be found in the bottom well, either attached to the glass cover slips or free in the bottom well.
Effects of LPF on phagocytosis and superoxide release. The effects of LPF on phagocytosis of EA and release of superoxide anion were examined by two different assay protocols. In protocol I, peritoneal cell suspensions containing 0, 2, or 20 ng of LPF per ml were prepared, and samples of these cells were added to the chemotaxis chamber for assay of macrophage migration. The remaining cells were added to culture wells to assay for phagocytosis or superoxide release after a 4-h preincubation. Zymosan-stimulated superoxide release was not changed significantly when migration was inhibited by more than 77% (Table 1) . At 2 ng of LPF per ml, phagocytosis was inhibited by 26% and migration was inhibited by 79% (Table 2 ). Therefore, LPF had little or no effect on superoxide release and a relatively small effect on phagocytosis of EA under assay conditions closely matching those used for the chemotaxis assay. Since effects of LPF in some other cell systems can be enhanced by longer exposure (22) , the assays were repeated, using a protocol in which macrophage monolayers were incubated in RPMI-2% FBS containing 0, 2 or 20 ng of LPF per ml for 18 to results obtained under the conditions of protocol I (Tables 1  and 2 ).
Reversal of inhibition by heat-inactivation of LPF or by treating LPF with specific anti-LPF antibody. Inhibition of macrophage migration by LPF was essentially eliminated when the LPF was heated at 80°C for at least 5 min (data not shown) or when LPF was premixed with antibodies directed toward LPF (Fig. 4 ). An affinity-purified goat antibody to LPF neutralized the inhibition of macrophage chemotaxis by LPF, whereas normal goat gamma globulin had no effect (Fig. 4A) . Two mouse monoclonal antibodies that reacted with LPF in an enzyme-linked immunosorbent assay were also examined. One antibody (143C4D) neutralized nearly as well as the goat antibody, whereas the second antibody (132D) did not reduce the ability of LPF to inhibit migration (Fig. 4B) . The two monoclonal antibodies either recognize different epitopes on the LPF molecule or bind with different affinities to the LPF molecule.
LPF is not a chemoattractant for murine peritoneal macrophages. Some bacterial components have been demonstrated to be chemoattractants for phagocytic cells (41) , and it is probable that an attractant added only to the upper well would inhibit migration through a membrane filter. LPF, however, was an equally effective inhibitor of chemotaxis and random migration when the negative gradient of LPF was eliminated by adding equal concentrations of LPF to the upper and lower chambers. Additionally, it was demonstrated directly that LPF was not an attractant for murine resident peritoneal macrophages at the concentrations used in this study by experiments in which LPF (at 0.02 to 20 ng/ ml) was added only to the lower (attractant) well with or without a gradient of EAMS. In all cases and at all LPF doses, migration was either the same as that in controls or reduced. Reduction probably was due to inhibitory levels of LPF diffusing through the membrane.
Morphology of LPF-treated macrophages. During these studies, it was noted that LPF-treated macrophages often appeared more rounded than control macrophages. Therefore, experiments were designed to examine the morphology of cells treated with LPF under conditions similar to those in which inhibition of random migration was observed. Peritoneal cells with or without LPF were added to Lab-Tek tissue culture slides and examined after a 4-h incubation. After lymphocytes and nonadherent cells were washed off the slides, the attached cells were fixed and stained. The number of adherent cells was shown in parallel cultures to be equivalent in wells with or without LPF. Most control cells spread out on the glass and appeared in scanning electron microscopy as flattened and elongated cells (Fig. 5, left) . In contrast, LPF-treated macrophages (Fig. 5, right) were rounded up but otherwise exhibited normal surface morphology. Heated LPF (80°C for 15 min) did not produce this morphological alteration. Although accurate quantitation of this change in cell shape was not possible, it was observed that LPF concentrations that produced the morphological effect were similar to those that inhibited migration. DISCUSSION LPF inhibited random migration and chemotaxis of murine peritoneal macrophages and chemotaxis of a murine macrophage-like cell line, RAW264. The experiments with the C3H/HeN macrophages indicate that LPF has a specific effect on migration; attachment to glass or plastic surfaces and the release of superoxide were not significantly changed by LPF (Table 1) . Fc-mediated phagocytosis was significantly reduced, but it is likely that the phagocytic machinery remained intact, because the inhibition did not exceed 35% even at LPF concentrations 60-fold higher than those that inhibited migration by 50% (Table 2 ). It is possible that the reduced phagocytosis was caused by the decreased motility or altered morphology of the LPF-treated macrophage.
The results in Fig. 1 demonstrate that LPF does not inhibit migration simply by interfering with binding of the chemoattractant. The percentage of inhibition of migration was essentially the same at all attractant concentrations, including the random migration in the absence of attractant (i.e., 0% EAMS).
The ability of LPF to inhibit the migration of the cloned RAW264 macrophage-like murine cell line (Fig. 3) indicates that LPF can inhibit directly the migrating cell and does not require the presence of lymphocytes or other regulatory cells. It requires, however, ca. 5-to 10-fold higher concentrations of LPF to inhibit the cell line than it does to inhibit migration of peritoneal macrophages. RAW264 may be somewhat less sensitive to LPF, or the effect may be enhanced by the presence of lymphocytes.
The morphological studies reported herein indicate that LPF-treated macrophages tend to be rounded up after a 4-h exposure to LPF. Since elongation and polarization are required for phagocyte locomotion (7, 53) , this morphological change is consistent with the observed decrease in migration. The effects are similar to those described by Benjamin et al. (4) , in which peritoneal macrophages obtained from mice injected with pertussis vaccine exhibited decreased random migration and elongation in vitro.
INFECT. IMMUN. Strong evidence has been presented that the inhibition of macrophage migration is mediated by LPF and not by contaminants in the preparation. This conclusion is supported by the high degree of purity of the protein (42) and the neutralization of the effect by both polyclonal and monoclonal antibodies specific for LPF. The following evidence supports the interpretation that the observed effects of purified LPF were not caused by either the endotoxin or the extracytoplasmic adenylate cyclase of B. pertussis, two components known or suspected to alter MNP function. (i) Purified LPF was shown by the limulus amebocyte lysate assay to contain less than 0.02% (wt/wt) contamination of endotoxin activity. (ii) The inhibitory effect on macrophages was significantly reduced when the LPF was heated for 5 min at 80°C. (iii) The LPF inhibition curves were virtually identical in the endotoxin hyporesponsive C3H/HeJ mice and the endotoxin responsive C3H/HeN mice ( Fig. 2 and 3 (5, 17, 32) . Studies are underway to determine whether ADP-ribosylation of the inhibitory subunit occurs in the membrane of the macrophage and whether this event accounts for the functional and morphological changes seen in this study. Alternatively, the effects on macrophages may be caused by the ADP-ribosylation of some other component or by binding of the LPF to a membrane structure required for motility. Some agents which increase cyclic AMP levels inhibit migration or induce morphological changes in MNPs (6, 14, 35, 36, 44) . However, the mechanism by which these changes occur, and the relationship to the current study, is not yet clear.
It has been reported that urea extracts of B. pertussis cells, when incubated with phagocytic cells, inhibited chemotaxis, superoxide release, microbial killing, and chemiluminescence (9, 48) and also induced a rapid (30-min) rise in cytoplasmic cyclic AMP (9) . We have demonstrated that LPF alone inhibited migration, while having no effect on oxidative metabolism. Although urea extracts of B. pertussis contain LPF (25, 48) , our results with purified LPF are compatible with the conclusion of Confer and Eaton that the bacterial extracytoplasmic adenylate cyclase in their extract and not LPF was required for the broad spectrum of effects on phagocytic cells. Confirmation requires further purification of the active component(s) of the urea extract. Ogawa et al. (34) recently reported that LPF had chemotactic activity for human monocytes. When LPF was added only to the lower (attractant) chamber, a stimulation of migration occurred with a peak activity at 1 ,ug/ml. No inhibition of random migration was seen. Because of considerable differences in experimental protocols, these results do not contradict the results presented here. A major difference is that the concentrations that stimulated chemotaxis of human monocytes were 1,000-fold higher than the concentrations shown to inhibit murine macrophage migration. At high concentrations (ca. 1 jig/ml), LPF demonstrates lectinlike properties (29, 39) , and it has been observed that several lectins are chemotactic for human monocytes and polymorphonuclear leukocytes (24, 46 (13, 26) ; murine resident peritoneal macrophages do not begin to migrate until hour 2 of the assay (26) , whereas the migration of human monocytes is essentially complete in 60 min (13) . Since ADP-ribosyl transferase-dependent effects of LPF require a minimum exposure of 60 min (22, 32) Other bacterial toxins and microbial products have been shown to alter phagocytic cell function; the role that these toxins may play in disease has been recently reviewed (11, 50) . Considerable work must be done to determine whether the effect of LPF on macrophage migration has a role in the establishment of infection and subsequent disease. In particular, this work must be expanded to determine whether LPF has the same effects on human monocytes and alveolar macrophages. It appears that B. pertussis produces at least two toxins, LPF and the extracytoplasmic adenylate cyclase, which may alter phagocytic cell function. We propose that disseminated LPF inhibits recruitment of MNPs into the site of infection, whereas the adenylate cyclase acts to reduce the bactericidal activity of those phagocytes present at the infection site. Through these mechanisms, both toxins may have an important role in establishing and maintaining the local infection.
